From: Drugs utilization profile in England and Wales in the past 15 years: a secular trend analysis
Therapeutic class | Rate of prescribing in 2004 per 100,000 persons (95% CI) | Rate of prescribing in 2019 per 100,000 persons (95% CI) | Percentage change from 2004 – 2019 |
---|---|---|---|
Gastro-intestinal system medications | 103,465.69 (103,439.86 – 103,491.52) | 180,617.77 (180,586.84 – 180,648.69) | 74.6% |
Cardiovascular system medications | 407,305.61 (407,263.94 – 407,347.28) | 584,695.14 (584,655.52 – 584,734.76) | 43.6% |
Respiratory system medications | 102,509.91 (102,484.19 – 102,535.64) | 130,550.51 (130,523.43 – 130,577.60) | 27.4% |
Central nervous system medications | 247,629.78 (247,593.18 – 247,666.39) | 381,689.81 (381,650.75 – 381,728.86) | 54.1% |
Infections medications | 82,616.61 (82,606.44 – 82,626.77) | 74,498.74 (74,487.66 – 74,509.82) | -9.8% |
Endocrine system medications | 109,310.42 (109,283.96 – 109,336.88) | 200,804.09 (200,771.88 – 200,836.29) | 83.7% |
Obstetrics, gynaecology, and urinary-tract disorders medications | 32,262.91 (32,250.38 – 32,275.45) | 54,914.09 (54,901.44 – 54,926.74) | 70.2% |
Malignant disease and immunosuppression medications | 8,029.08 (8,021.80 – 8,036.37) | 8,385.11 (8,378.07 – 8,392.16) | 4.4% |
Nutrition and blood-related products | 42,954.03 (42,936.83 – 42,971.22) | 108,515.77 (108,490.76 – 108,540.77) | 152.6% |
Musculoskeletal and joint diseases medications | 59,759.91 (59,746.76 – 59,773.06) | 56,369.73 (56,357.12 – 56,382.34) | -5.7% |
Eye medications | 31,691.22 (31,678.75 – 31,703.70) | 33,348.64 (33,336.65 – 33,360.62) | 5.2% |
Ear, nose, and oropharynx medications | 18,844.39 (18,833.90 – 18,854.88) | 20,726.21 (20,715.90 – 20,736.51) | 10.0% |
Skin medications | 69,938.78 (69,926.49 – 69,951.08) | 57,095.46 (57,082.88 – 57,108.05) | -18.4% |
Immunological products and vaccines | 27,124.69 (27,112.77 – 27,136.62) | 22,835.83 (22,825.15 – 22,846.50) | -15.8% |
Anaesthesia | 1,652.72 (1,649.30 – 1,656.14) | 3,091.59 (3,087.19 – 3,095.99) | 87.1% |